United Kingdom

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Capital Market

15 Nov 2018
Change (% chg)

$0.07 (+3.65%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Ann Merrifield

67 2017 Chairman of the Board

Richard Toselli

60 2018 President, Acting Chief Executive Officer and Chief Medical Officer, Director

Jeff Modestino

2018 Principal Financial Officer, Principal Accounting Officer

Melanie Morel-Ferris

36 2017 Senior Director, Finance and Controller

Tamara Joseph

53 2014 Senior Vice President, Chief Compliance Officer, General Counsel